Converse Faces Job Cuts as Nike Aims for $2 Billion in Cost Savings 
Rishi Sunak wants to cut the cost of ‘sicknote’ Britain 
Aldi, Hy-Vee Recall Cream Cheese Products Over Potential Salmonella Contamination 
How supermarkets are changing their branding to make you think they’re cheaper 
Supporting ‘democracy’ is hard for many who feel government and the economy are failing them 
The UK has become the world’s fourth largest exporter, but can it maintain this momentum? 
From Burger King to McDonald’s: Fast-Food Prices Surge Dramatically in Recent Years 
Nike vs. Adidas: Anthony Edwards’ and Wembanyama’s Sneakers Soar in Popularity 
Coca-Cola Launches Lens Platform to Offer Key Data for Retail and Foodservice 
Mortgage prisoners: regulatory changes and low credit scores have left thousands trapped in a cycle of high payments 
Semaglutide's Benefits Beyond Weight Loss: New Insights from the SELECT Trial 
Burger King’s Largest Franchisee Carrols, Acquired by RBI for $1 Billion, $500M Revamp 
Johnson & Johnson is set to pay $230 million to settle a legal case over claims it encouraged and bolstered the opioid addiction predicament in the state of New York. Then again, it was mentioned that despite settling, the company did not acknowledge liability or any wrongdoing in what it was accused of.
What the J&J settlement means
As per BBC News, Johnson & Johnson settlement effectively prevented it from going to trial that is set to start on Tuesday, June 29. The hearing will present a number of opioid manufacturers and distributors as the defendants of the case.
The company said that its agreements with New York State are proportionate with the previous resolution to pay $5 billion to settle the opioid claims. It was added that the arrangement also requires Johnson & Johnson to discontinue the sale of painkillers across the country.
"The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids," Letitia James, the New York attorney general, said. "Johnson & Johnson helped fuel this fire, but today they're committing to leaving the opioid business - not only in New York but across the entire country."
J&J to take its problematic painkillers off the market
It was mentioned that addiction to opioids, both legal and illegal drugs, has become a serious issue, and this problem is ongoing in countries like the United States. In fact, based on the record of the Centers for Disease Control and Prevention, the country reported almost half a million deaths due to overdoses between the years 1999 and 2019.
While Johnson & Johnson is set to be removed from the trial in New York, it is still facing similar cases in other states such as California. At any rate, the deal with New York also asked the company to stop selling opioids, and it was learned that J&J already did so for some time now.
CNBC reported that Johnson & Johnson confirmed it has ended its opioid business a while ago, even before the settlement with New York. Since 2015, the company stopped marketing opioids in the U.S. and totally withdrew from the business in 2020.
